Abstract
Parkinson disease (PD) patients may experience nonmotor symptoms (NMS) before Parkinsonism onset. Patients with idiopathic REM sleep behavior disorder (IRBD) eventually develop PD and may represent premotor PD. We aimed to evaluate the prevalence and perceived timeline of NMS in IRBD through validated scales and questionnaires used in PD research. In 44 IRBD patients and 40 matched controls, overall NMS evaluation was assessed by NMS questionnaire for Parkinson disease, olfaction by University of Pennsylvania Smell Identification Test, dysautonomia by scales for outcomes in Parkinson’s disease-autonomic, constipation by Rome III criteria, depression by Hospital Anxiety and Depression Scale, cognitive impairment by Montreal cognitive assessment (MoCA) and hypersomnia by Epworth Sleepiness Scale. Patients were asked to report the perceived time of onset of hyposmia, constipation, and depression. Hyposmia (52.3 vs. 20.0 %, p = 0.002) and constipation (56.8 vs. 20.0 %, p = 0.001) were more frequent in patients than in controls. Patients reported more memory problems and showed a trend toward lower score in MoCA. Depression and hypersomnia were not more frequent in patients. The first symptom perceived was RBD in 38.6 % patients, hyposmia in 15.9 %, constipation in 11.4 %, and depression in 6.8 %. The temporal course of the NMS studied was heterogeneous. The three most common presentations were RBD followed by hyposmia; hyposmia followed by RBD; and hyposmia followed by RBD and constipation occurring at the same time span. IRBD patients frequently exhibit NMS that occur in premotor PD, particularly hyposmia and constipation. In IRBD, the perceived timeline of NMS is highly variable. This variability may suggest that pathological changes occurring in IRBD subjects are also heterogeneous and not restricted to the structures that regulate REM sleep.
Similar content being viewed by others
References
Tolosa E, Wenning G, Poewe W (2006) The diagnosis of Parkinson’s disease. Lancet Neurol 5:75–86
Spillantini MG, Goedert M (2000) The alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 920:16–27
Fearnley JM, Lees AJ (1991) Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114:2283–2301
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5:235–245
Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24:1641–1649
Mollenhauer B, Trautmann E, Sixel-Döring F et al (2013) Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology 81:1226–1234
Müller B, Larsen JP, Wentzel-Larsen T, Skeie GO, Tysnes OB, Parkwest Study Group (2011) Autonomic and sensory symptoms and signs in incident, untreated Parkinson’s disease: frequent but mild. Mov Disord 26:65–72
Pont-Sunyer C, Hotter A, Gaig C et al (2014) The onset of nonmotor symptoms in Parkinson’s disease (The ONSET PD Study). Mov Disord. doi:10.1002/mds.26077
Tolosa E, Gaig C, Santamaría J, Compta Y (2009) Diagnosis and the premotor phase of Parkinson disease. Neurology 72(Suppl 2):S12–S20
Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
Boeve BF (2010) REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 1184:15–54
Arnulf I (2012) REM sleep behaviour disorder: motor manifestations and pathophysiology. Mov Disord 27:677–689
Schenck C, Boeve B, Mahowald M (2013) Delayed emergence of a parkinsonian disorder or dementia in 81 % of older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder: a 16-year update on a previously reported series. Sleep Med 14:744–748
Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M et al (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behavior disorder: an observational cohort study. Lancet Neurol 12:443–453
Postuma RB, Gagnon JF, Montplaisir J (2013) Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years. Sleep Med 14:763–767
American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3rd edn. American Academy of Sleep Medicine, Darien
Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest Study. Mov Disord 21:916–923
Martinez-Martin P, Schapira AHV, Stocchi F, Sethi K, Odin P, MacPhee G et al (2007) Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629
Doty RL (1995) The smell identification TestTM administration manual, 3rd edn. Sensonics Inc, Philadephia
Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130:1480–1491
Zigmond AS, Snaith RP (1983) The Hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370
Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52:69–77
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545
Chiba Y, Fujishiro H, Iseki E et al (2012) Retrospective survey of prodromal symptoms in dementia with Lewy bodies: comparison with Alzheimer’s disease. Dement Geriatr Cogn Disord 33:273–281
Fujishiro H, Iseki E, Nakamura S et al (2013) Dementia with Lewy bodies: early diagnostic challenges. Psychogeriatrics 13:128–138
Ferman TJ, Smith GE, Kantarci K et al (2013) Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology 81:2032–2038
Donaghy PC, O’Brien JT, Thomas AJ (2014) Prodromal dementia with Lewy bodies. Psychol Med 3:1–10
Kim HJ, Park SY, Cho YJ et al (2009) Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci 287:200–204
Gaenslen A, Swid I, Liepelt-Scarfone I, Godau J, Berg D (2011) The patients’ perception of prodromal symptoms before the initial diagnosis of Parkinson’s disease. Mov Disord 26:653–658
Khoo TK, Yarnall AJ, Duncan GW et al (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80:276–281
Erro R, Santangelo G, Picillo M et al (2013) Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients. Parkinsonism Relat Disord 19:256–259
Stiasny-Kolster K, Doerr Y et al (2005) Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126–137
Fantini ML, Postuma RB, Montplaisir J, Ferini-Strambi L (2006) Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res Bull 70:386–390
Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir J (2011) Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 69:811–818
Mahlknecht P, Iranzo A, Högl B et al (2015) Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. Neurology 2015(84):1–5
Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244
Ponsen MM, Stoffers D, Booji J, van Eck-Smit BLF, Ech Wolters, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol 56:173–181
Ross Petrovitch H, Abbot RD et al (2008) Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol 63:167–173
Iranzo A, Serradell M, Vilaseca I et al (2013) Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord 19:600–604
Hoyles K, Sharama JC (2013) Olfactory loss as a supporting feature in the diagnosis of Parkinson disease: a pragmatic approach. J Neurol 260:2951–2958
Olichney JM, Murphy C, Hofsteffer CR et al (2005) Anosmia is very common in the Lewy body variant of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 76:1342–1347
Westervelt HJ, Stern RA, Tremont G (2003) Odor identification deficits in diffuse Lewy body disease. Cogn Behav Neurol 16:93–99
Postuma RB, Lang A, Massicotte-Marquez J, Montplaisir J (2006) Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 66:845–851
Postuma RB, Gagnon JF, Vendette M, Montplaisir JY (2009) Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson’s disease. Brain 132:3298–3307
Postuma RB, Gagnon JF, Pelletier A, Montplaisir J (2013) Prodromal autonomic symptoms and signs in Parkinson’s disease and dementia with Lewy bodies. Mov Disord 28:597–604
Ferini-Strambi L, Oertel W, Dauvilliers Y, Postuma RB, Marelli S, Iranzo A et al (2014) Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study. J Neurol 261:1112–1118
Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD et al (2001) Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology 57:456–462
Olanow CW, Wakeman DR, Kordower JH (2014) Peripheral alpha-synuclein and Parkinson’s disease. Mov Disord 29:963–966
Gelpi E, Navarro-Otano J, Tolosa E (2014) Multiple organ involvement in alpha-synuclein pathology in Lewy body disorders. Mov Disord 29:1010–1018
Iranzo A, Gelpi E, Tolosa E (2014) Neuropathology of prodromal Lewy body disease. Mov Disord 29:410–415
Frauscher B, Nomura T, Duerr S et al (2012) Investigation of autonomic function in idiopathic REM sleep behavior disorder. J Neurol 259:1056–1061
Santamaría J, Tolosa E, Valles A (1986) Parkinson’s disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 36:1130–1133
Shiba M, Bower JH, Maraganore DM et al (2000) Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case control study. Mov Disord 15:669–677
Leentjens AFG, Van den Akker M, Metsemakers JFM, Lousberg R, Verhey FRJ (2003) Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord 18:414–418
Ferini-Strambi L, Di Gioia MR, Castronovo V, Oldani A, Zucconi M, Cappa SF (2004) Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD). Does the idiopathic form of RBD really exist? Neurology 62:41–45
Massicotte-Marquez J, Décary A, Gagnon JF, Vendette M, Mathieu A, Postuma RB, Carrier J, Montplaisir J (2008) Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology 70:1250–1257
Aarsland D, Bronnick K, Larsen JP, Tusnes OB, Alves D, for the Norwegian Park West Study Group (2009) Cognitive impairment in incident, untreated Parkinson disease The Norwegian Park West Study. Neurology 72:1121–1126
Yarnall AJ, Breen DP, Duncan DP et al (2014) Characterizing mild cognitive impairment in incident Parkinson disease. The ICICLE study. Neurology 82:308–316
Abbott RD, Ross GW, White LR et al (2005) Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65:1442–1446
Gao J, Huang X, Park Y et al (2011) Daytime napping, nighttime sleeping, and Parkinson disease. Am J Epidemiol 173:1032–1038
Schenck CH, Mahowald MW (2002) REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002(25):120–138
Buskova J, Klempir J, Majerova V et al (2011) Sleep disturbances in untreated Parkinson’s disease. J Neurol 258:2254–2259
Plomhause L, Dujardin K, Duhamel A et al (2013) Rapid eye movement sleep behavior disorder in treatment-naïve Parkinson disease patients. Sleep Med 14:1035–1037
Prudon B, Duncan GW, Khoo TK, Yarnall AJ, Anderson KN (2014) Primary sleep disorder prevalence in patients with newly diagnosed Parkinson’s disease. Mov Disord 29:259–262
Iranzo A (2011) Sleep-wake changes in the premotor stage of Parkinson disease. J Neurol Sci 310:283–285
Boeve BF (2013) Idiopathic REM sleep behavior disorder in the development of Parkinson’s disease. Lancet Neurol 12:469–482
Jellinger KA (2012) Neuropathology of sporadic Parkinson’s disease: evaluation and change of concepts. Mov Disord 27:8–30
Del Tredici K, Braak H (2012) Lewy pathology and neurodegeneration in premotor Parkinson’s disease. Mov Disord 27:597–607
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical standard
The study was approved by the Ethical Committee of Hospital Clínic de Barcelona and was conducted according to the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aguirre-Mardones, C., Iranzo, A., Vilas, D. et al. Prevalence and timeline of nonmotor symptoms in idiopathic rapid eye movement sleep behavior disorder. J Neurol 262, 1568–1578 (2015). https://doi.org/10.1007/s00415-015-7742-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-015-7742-3